Hospital
Ascension Wisconsin Emerus Menomonee Falls, LLC
Ascension Wisconsin Emerus Menomonee Falls, LLC was paid $1.11M by Medicaid between Dec 2021 and Dec 2024, across 52 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoASCENSION WISCONSIN EMERUS MENOMONEE FALLS, LLC
MILWAUKEE, WI 53220
MILWAUKEE, WI 53220
33aNPI1255938510assigned 10/08/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.11M
24GClaims42,909
24DCodes billed52
24AFirst – last monthDec 2021 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#40 of 60
Median peer was paid$2.90M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 81 | $3K | |
| 2022 | 11,056 | $251K | |
| 2023 | 16,368 | $417K | |
| 2024incomplete | 15,404 | $436K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 6,060 | 5,420 | $383K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 2,826 | 2,524 | $179K |
| 96361 | Intravenous infusion, hydration; each additional hour | 10% | 843 | 698 | $112K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.3% | 1,726 | 1,538 | $103K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.6% | 1,450 | 1,335 | $95K |
| 87428 | 4.3% | 1,464 | 1,334 | $47K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 301 | 275 | $22K |
| 80051 | 1.6% | 1,516 | 1,294 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 2,830 | 2,397 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 785 | 722 | $15K |
| 80053 | Comprehensive metabolic panel | 1.4% | 1,396 | 1,204 | $15K |
| 81003 | 1.2% | 2,160 | 1,942 | $13K |
40 more codes
| 81025 | <1% | 1,426 | $11K | |
| 84484 | <1% | 816 | $8K | |
| 82550 | <1% | 1,535 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 186 | $7K |
| 82565 | <1% | 1,519 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 93 | $6K |
| 82947 | <1% | 1,737 | $6K | |
| 87420 | <1% | 103 | $4K | |
| 84520 | <1% | 1,511 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 74 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 58 | $2K |
| 82977 | <1% | 384 | $2K | |
| 87634 | <1% | 73 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 89 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 33 | $2K |
| 82150 | <1% | 388 | $2K | |
| 84460 | <1% | 377 | $2K | |
| 84075 | <1% | 377 | $1K | |
| 84450 | <1% | 377 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 19 | $1K |
| 82040 | <1% | 377 | $1K | |
| 82247 | <1% | 377 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 59 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 59 | $1K |
| 84155 | <1% | 377 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,606 | $422.89 |
| 83605 | <1% | 48 | $384.04 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 16 | $327.13 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 749 | $312.89 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 76 | $246.02 |
| 71045 | Radiologic examination, chest; single view | <1% | 939 | $204.40 |
| 85379 | <1% | 25 | $191.81 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,156 | $174.97 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 284 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 18 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 31 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 1,332 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 476 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 359 | $0.00 |
| 73610 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHMERBECK, VICTOR (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ascension Wisconsin Emerus Menomonee Falls, LLC | Menomonee Falls, WI | $1.83M |
| HCN Ep Horizon City, LLC | El Paso, TX | $1.18M |
| Ascension Wisconsin Emerus Menomonee Falls, LLC | Waukesha, WI | $308K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.